Lobbying Filing Details

Total Spending

$2,090,000

Activities

15

Lobbyists

25

Gov't Entities

225

Filing Information
Filing UUID:
1fdfc7fd-f079-498e-8a15-27007fb9f897
Type:
Q4 - 4th Quarter - Report
Period:
2014 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 20, 2015 at 11:25 PM
Income:
$0
Expenses:
$2,090,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Brent DelMonte, Vice President for Federal Government Relations
Registrant
BIOTECHNOLOGY INNOVATION ORGANIZATION

Trade Association

Washington, District of Columbia
Client
BIOTECHNOLOGY INNOVATION ORGANIZATION
District of Columbia, United States of America
Lobbying Activities (15)
Activity 1
Agriculture

Genetically Engineered (GE) Animals
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015
Amendment on GE Salmon LabelingReview and Labeling of Food Derived From Biotechnology
H.R. 4432: Safe and Accurate Food Labeling Act

Foreign Agricultural Biotechnology Laws and Regulations
China Biotechnology Regulations
Asynchrony of International Approvals

Funding for Biomass Crop Assistance Program
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Transatlantic Trade and Investment Partnership
Ag-Biotech Issues

USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products

Lobbyists (6)
  • MR. BRENT ALAN DELMONTE
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • JOSEPH DAMOND
  • CATHLEEN ENRIGHT
  • MR. MATTHEW O'MARA
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 2
Animals

Genetically Engineered (GE) Animals
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015
Amendment on GE Salmon Labeling

Lobbyists (2)
  • MR. BRENT ALAN DELMONTE
  • TRACEY LATURNER
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 3
Budget/Appropriations

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015Funding for FDA
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Funding for Centers for Disease Control and Prevention Vaccine Programs
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Funding for National Institutes of Health
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Funding for Biomass Crop Assistance Program
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Sequestration of PDUFA Fees
HR 2725: Food and Drug Administration Safety over Sequestration Act of 2013
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Energy Basic Research Funding
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Funding for Renewable Chemicals/Bio-based Products
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Funding for Biofuels
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Lobbyists (9)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • ANDREW EMMETT
  • PHYLLIS ARTHUR
  • TRACEY LATURNER
  • RINA SINGH
  • KELLY CAPPIO
  • DERRICK M WHITE
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 4
Consumer Issues/Safety/Products

USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech ProductsGenetically Engineered (GE) Animals
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015
Amendment on GE Salmon Labeling

Review and Labeling of Food Derived From Biotechnology
H.R. 4432: Safe and Accurate Food Labeling Act

Funding for FDA
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Drug Evaluation and Review
Implementation of the FDA Safety and Innovation Act

Biosimilars
Colombia Biologics Regulations
Implementation of Affordable Care Act
Interchangeability and Pharmacy Substitution
Naming

Sunshine Act Implementation

Lobbyists (14)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • ANDREW EMMETT
  • SARA RADCLIFFE
  • TOM DILENGE
  • MS. ANNA KATHERINE WEINSTEIN
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • CATHLEEN ENRIGHT
  • MS. A. CATHARINE HARRIS
  • JEFFREY PETERS
  • DERRICK M WHITE
  • MR. MATTHEW O'MARA
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 5
Copyright/Patent/Trademark

Clinical Trial Data Sharing and Disclosure
Canadian Policies
European PoliciesPatent Reform
H.R. 2024: End Anonymous Patents Act
H.R. 3309: Innovation Act of 2013
H.R. 845: The SHIELD Act of 2013
S. 1013: Patent Abuse Reduction Act of 2013
S. 1720: Patent Transparency and Improvements Act of 2013
Targeting Rogue and Opaque Letters (TROL) Act of 2014 (Discussion Draft)
Implementation of H.R. 1249: The America Invents Act of 2011
FTC Regulation of Patent Demand Letters (Senator Commerce Committee Discussion Draft)

World Trade Organization Special 301 Submissions

TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals

Transatlantic Trade and Investment Partnership
Intellectual Property Issues

Trade Promotion Authority
H.R. 3830/S. 1900: Bipartisan Congressional Trade Priorities Act of 2014

Patenting of Biological Inventions
PTO Examination Guidelines

DNA Patenting and Licensing

Lobbyists (8)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • TOM DILENGE
  • HANSJORG SAUER
  • MS. ANNA KATHERINE WEINSTEIN
  • JOSEPH DAMOND
  • MR. CHARLES H FRITTS
  • DERRICK M WHITE
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 6
Energy/Nuclear

Funding for Biofuels
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015Biofuels
Accelerated Depreciation Extension
Implementation of the Agricultural Act of 2014
Production Tax Credit Extension
Renewable Fuel Standard
S. 2260: EXPIRE Act of 2014

Renewable Chemicals/Bio-based Products
Expansion of Master Limited Partnerships to Renewable Chemicals
Implementation of the Agricultural Act of 2014
H.R. 1696/S. 795: Master Limited Partnerships Parity Act
H.R. 2421: Renewable Chemicals Parity Act
S. 2260: EXPIRE Act of 2014

Funding for Biomass Crop Assistance Program
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Energy Basic Research Funding
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Funding for Renewable Chemicals/Bio-based Products
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Lobbyists (6)
  • MR. BRENT ALAN DELMONTE
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • RINA SINGH
  • MR. CHARLES H FRITTS
  • ERICK LUTT
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 7
Environment/Superfund

EPA Regulation of Biotechnology

Lobbyists (1)
  • RINA SINGH
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 8
Food Industry (safety, labeling, etc.)

Review and Labeling of Food Derived From Biotechnology
H.R. 4432: Safe and Accurate Food Labeling ActGenetically Engineered (GE) Animals
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015
Amendment on GE Salmon Labeling

Lobbyists (5)
  • MR. BRENT ALAN DELMONTE
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • CATHLEEN ENRIGHT
  • MR. MATTHEW O'MARA
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 9
Fuel/Gas/Oil

Funding for Biofuels
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015Biofuels
Accelerated Depreciation Extension
Implementation of the Agricultural Act of 2014
Production Tax Credit Extension
Renewable Fuel Standard
S. 2260: EXPIRE Act of 2014

Renewable Chemicals/Bio-based Products
Expansion of Master Limited Partnerships to Renewable Chemicals
Implementation of the Agricultural Act of 2014
H.R. 1696/S. 795: Master Limited Partnerships Parity Act
H.R. 2421: Renewable Chemicals Parity Act
S. 2260: EXPIRE Act of 2014

Funding for Biomass Crop Assistance Program
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Energy Basic Research Funding
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Funding for Renewable Chemicals/Bio-based Products
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Lobbyists (6)
  • MR. BRENT ALAN DELMONTE
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • RINA SINGH
  • MR. CHARLES H FRITTS
  • ERICK LUTT
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 10
Health Issues

Affordable Care Act Implementation
Third Party Support of Patient Premiums and Cost-Sharing Obligations21st Century Cures Initiative
Biomarkers and Regulatory Science Improvements
Communication with Healthcare Professionals
Expanded Access to Investigational Drugs
Expedited Pathways
FDA Hiring Flexibility
FDA Management and Financial Accountability
Innovation Incentives
Longitudinal Study of Chronic Diseases
Patient Access to Approved Drugs
Patient-Focused Drug Development
Use of Real-World Evidence
Vaccine and Anti-Microbial Resistance Product Development and Incentives

Combating Antibiotic-Resistant Bacteria (CARB) Initiative

Biosimilars
Biosimilar User Fee Act Implementation
Colombia Biologics Regulations
Implementation of Affordable Care Act
Interchangeability and Pharmacy Substitution
Naming
Patent Certification

Funding for National Institutes of Health
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Funding for Centers for Disease Control and Prevention Vaccine Programs
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

340B Drug Pricing Program
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015
Implementation of Affordable Care Act
Program Implementation & Oversight

Funding for FDA
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Independent Payment Advisory Board

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

TransPacific Partnership
Regulatory Transparency
Data and Intellectual Property Protections for Pharmaceuticals

Transatlantic Trade and Investment Partnership
Regulatory Harmonization
Reimbursement Issues
Intellectual Property IssuesReimbursement for Innovative Products
H.R. 1416: Cancer Patient Protection Act of 2013
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
CMS Proposed Rule on Protected Classes

Sequestration of PDUFA Fees
HR 2725: Food and Drug Administration Safety over Sequestration Act of 2013
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Drug Evaluation and Review
Implementation of the FDA Safety and Innovation Act

Orphan Drug Act Tax Credit

Clinical Trial Data Sharing and Disclosure
Canadian Policies
European Policies

Sunshine Act Implementation

Lobbyists (20)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • ANDREW EMMETT
  • SARA RADCLIFFE
  • TOM DILENGE
  • SHELLY MUI-LIPNIK
  • HANSJORG SAUER
  • LAUREL TODD
  • MS. ANNA KATHERINE WEINSTEIN
  • PHYLLIS ARTHUR
  • TRACEY LATURNER
  • JOSEPH DAMOND
  • KELLY CAPPIO
  • CHARLES CRAIN
  • MR. CHARLES H FRITTS
  • MS. A. CATHARINE HARRIS
  • JEFFREY PETERS
  • KATHLEEN "KAY" HOLCOMBE
  • DERRICK M WHITE
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 11
Medical/Disease Research/Clinical Labs

Funding for National Institutes of Health
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

21st Century Cures Initiative
Longitudinal Study of Chronic Diseases

Combating Antibiotic-Resistant Bacteria (CARB) Initiative

Lobbyists (12)
  • MR. BRENT ALAN DELMONTE
  • SARA RADCLIFFE
  • TOM DILENGE
  • MS. ANNA KATHERINE WEINSTEIN
  • PHYLLIS ARTHUR
  • TRACEY LATURNER
  • KELLY CAPPIO
  • MS. A. CATHARINE HARRIS
  • JEFFREY PETERS
  • KATHLEEN "KAY" HOLCOMBE
  • DERRICK M WHITE
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 12
Medicare/Medicaid

21st Century Cures Initiative
Patient Access to Approved DrugsReimbursement for Innovative Products
H.R. 1416: Cancer Patient Protection Act of 2013
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
CMS Proposed Rule on Protected Classes

Lobbyists (10)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • SARA RADCLIFFE
  • LAUREL TODD
  • MS. ANNA KATHERINE WEINSTEIN
  • PHYLLIS ARTHUR
  • KELLY CAPPIO
  • MS. A. CATHARINE HARRIS
  • JEFFREY PETERS
  • DERRICK M WHITE
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 13
Small Business

Sarbanes Oxley Section 404 (b)
H.R. 1564/S. 1526: The Audit Integrity and Job Protection ActCapital Formation Investment Incentives
Reform of Capital Gains Rules
Reform of Net Operating Loss Rules
Reform of Passive Loss Rules
S. 1658: The Start-up Jobs and Innovation Act
S. 2260: EXPIRE Act of 2014
H.R. 4855, the PARTNER Act

Expansion of Exemption under SEC Regulation A
Proposed SEC Rule on Reg A+
H.R. 4565: Startup Capital Modernization Act

Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions
H.R. 2629: The Fostering Innovation Act

XBRL Exemption for Small Public Companies
H.R. 5405: The Promoting Job Creation and Reducing Small Business Burdens Act
H.R. 4164: Small Company Disclosure Simplification Act

Stock Exchange Tick Size
H.R. 5405: Promoting Job Creation and Reducing Small Business Burdens Act
H.R. 3448: The Small Cap Liquidity Reform Act

Capital Market Enhancements
H.R. 4568: Small Business Freedom to Grow Act
H.R. 3623: Improving Access to Capital for Emerging Growth Companies Act
H.R. 4697: To require the SEC to revise the definition of a WKSI to reduce the worldwide market
value threshold under the definition
H.R. 4569: Disclosure Modernization and Simplification Act
H.R. 4571: To direct the SEC to revise its rules so as to increase the threshold amount for
requiring issuers to provide certain disclosures relating to compensatory benefits plans

Lobbyists (5)
  • MR. BRENT ALAN DELMONTE
  • SHELLY MUI-LIPNIK
  • CHARLES CRAIN
  • MR. CHARLES H FRITTS
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 14
Taxation/Internal Revenue Code

Renewable Chemicals/Bio-based Products
S. 2260: EXPIRE Act of 2014Biofuels
Accelerated Depreciation Extension
Production Tax Credit Extension
S. 2260: EXPIRE Act of 2014

Research & Development Tax Credit Reforms
Extension
Permanency
H.R. 4438: American Research & Competitiveness Act of 2014
H.R.119: To amend the Internal Revenue Code to make permanent the credit for increasing
research activities
S. 2260: EXPIRE Act of 2014
S. 2715: The COMPETE Act
S. 193: The Start-up Innovation Credit Act

Capital Formation Investment Incentives
Reform of Capital Gains Rules
Reform of Net Operating Loss Rules
Reform of Passive Loss Rules
S. 2260: EXPIRE Act of 2014
H.R. 4855, the PARTNER Act
S. 1658: The Start-up Jobs and Innovation Act
HR 4855: To amend the Internal Revenue Code of 1986 to provide an exception from the passive
loss rules for investments in high technology research small business pass-thru entities

Tax Reform

Orphan Drug Act Tax Credit

Controlled Foreign Corporation Look-Through Rule Extension
S. 2260: EXPIRE Act of 2014

Inversions
H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015

Lobbyists (9)
  • MR. BRENT ALAN DELMONTE
  • TOM DILENGE
  • SHELLY MUI-LIPNIK
  • RINA SINGH
  • CHARLES CRAIN
  • MR. CHARLES H FRITTS
  • ERICK LUTT
  • DERRICK M WHITE
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more
Activity 15
Trade (domestic/foreign)

Foreign Agricultural Biotechnology Laws and Regulations
China Biotechnology Regulations
Asynchrony of International ApprovalsWorld Trade Organization Special 301 Submissions

TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals
Regulatory Transparency

Transatlantic Trade and Investment Partnership
Ag-Biotech Issues
Intellectual Property Issues
Regulatory Harmonization
Reimbursement Transparency

Biosimilars
Colombia Biologics Regulations

Clinical Trial Data Sharing and Disclosure
Canadian Policies
European Policies

Trade Promotion Authority
H.R. 3830/S. 1900: Bipartisan Congressional Trade Priorities Act of 2014

Lobbyists (11)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • TOM DILENGE
  • HANSJORG SAUER
  • MS. ANNA KATHERINE WEINSTEIN
  • MR. DANA MAURICE O'BRIEN JR
  • JOSEPH DAMOND
  • CATHLEEN ENRIGHT
  • MR. CHARLES H FRITTS
  • DERRICK M WHITE
  • MR. MATTHEW O'MARA
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • ... and 10 more

Source: LDA.gov, data retrieved November 5, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.